Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a High-Tech vest replace wires after surgery?

NCT ID NCT04721405

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a wearable vest with multiple sensors to see if it could comfortably monitor patients after plastic surgery procedures like BodyTite and FaceTite. 44 adults wore the vest after their operation and rated how comfortable and easy it was to use. The goal was to see if this non-invasive device could be a practical tool for post-surgery care, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

44 people

The number who actually took part.

Started

Sep 2020

Finished

Apr 2021

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Male or female over the age of 18 years, healthy adults scheduled to undergo BodyTite and/or FaceTite procedures.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Signed informed consent to participate in the study. * Female and male subjects, at least 18 years of age at the time of enrolment * The patient is scheduled to undergo BodyTite and/or FaceTite procedures. * The patients should be willing to comply with the study procedure and schedule. Exclusion Criteria: * Pacemaker or internal defibrillator, or any other active electrical implant anywhere in the body. * Pregnancy and nursing. * Subject unwilling or unable to comply with wearing the Nanowear System 12 hours daily for at least 48 hours Up to 7 days * As per the practitioner's discretion, refrain from treating any condition that might make it unsafe for the patient

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Elective surgical procedures are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Zucker School of Medicine, Hofstra University

    New York, New York, 10019, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.